Wegovy (Semaglutide)
Save up to 60%
Available Options
0.25mg
1 pen
0.5mg
1 pen
1mg
1 pen
1.7mg
1 pen
2.4mg
1 pen
Important Information
- • A valid prescription is required for all orders
- • Orders are shipped within 3–7 business days
- • Express shipping with cold chain packaging to keep your medication safe and effective
Description
Wegovy is a once-weekly injectable prescription medication that contains semaglutide, a GLP-1 receptor agonist. It is FDA-approved for chronic weight management in adults who are obese (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition such as high blood pressure, Type 2 diabetes, or high cholesterol.
Wegovy mimics the action of glucagon-like peptide-1 (GLP-1), a natural hormone that regulates appetite and food intake. By activating GLP-1 receptors in the brain, Wegovy reduces hunger, increases feelings of fullness, slows gastric emptying, and ultimately supports significant and sustained weight loss. Clinical trials have shown that patients using Wegovy can lose an average of 15% of their body weight over time.
Wegovy is not indicated for use in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also not a treatment for Type 1 or Type 2 diabetes.
Fact Table
| Formula | C187H291N45O59 |
|---|---|
| License | EU EMA, US FDA |
| Chemical Name | Semaglutide |
| Dosage (Strength) |
|
| Route | Subcutaneous injection |
| Bioavailability | ~89% |
Directions
- Administer Wegovy once a week on the same day, with or without meals. Use a subcutaneous injection in the thigh, abdomen, or upper arm.
- Start with a low dose and increase gradually based on your doctor's instructions to minimize gastrointestinal side effects.
- Never share your injection pen with others.
Ingredients
Wegovy contains the active ingredient Semaglutide, formulated specifically for once-weekly subcutaneous administration.
Cautions
- Wegovy is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with MEN 2. Do not use if you are allergic to semaglutide or any ingredients in Wegovy.
- Patients should be monitored for symptoms of pancreatitis, gallbladder issues, kidney impairment, and potential changes in vision due to diabetic retinopathy.
- Store pens in a refrigerator (36–46°F / 2–8°C). After first use, pens may be stored at room temperature (up to 86°F / 30°C) for 28 days.
- Do not freeze.
Interactions
Wegovy slows gastric emptying and may affect the absorption of oral medications. Inform your healthcare provider of all medications, supplements, or herbal products you are currently taking before starting Wegovy.
Side Effects
- Common: nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite.
- Rare but serious: pancreatitis, gallbladder disease, kidney issues, and possible thyroid tumors. Seek medical attention if you experience severe or persistent symptoms.
Frequently Asked Questions
What is Wegovy used for?
Wegovy is approved for chronic weight management in adults who are obese or overweight and have at least one weight-related condition.
How does Wegovy help with weight loss?
Wegovy activates GLP-1 receptors in the brain to reduce hunger, enhance satiety, and slow gastric emptying—helping reduce calorie intake and support weight loss.
Is Wegovy the same as Ozempic?
Both contain semaglutide, but Wegovy is formulated at higher doses and specifically approved for weight loss, while Ozempic is approved for Type 2 diabetes.
How much weight can you lose with Wegovy?
Patients have lost up to 15% of their body weight in clinical trials, depending on adherence and lifestyle changes.
Is Wegovy approved for people without diabetes?
Yes, Wegovy is indicated for weight loss in people with or without Type 2 diabetes.
What are the side effects of Wegovy?
Common side effects include nausea, constipation, vomiting, diarrhea, and abdominal discomfort. Serious risks include pancreatitis and thyroid tumors.
How fast does Wegovy start working?
Appetite suppression begins within the first few doses. Noticeable weight loss typically begins within the first month of treatment.
Can Wegovy be used with other weight loss medications?
It depends. Consult your doctor before combining therapies, as overlapping side effects may occur.
Is Wegovy available internationally?
Yes, Wegovy has been approved for use in the U.S., Canada, Europe, and other markets.
Do I need to refrigerate Wegovy?
Yes, before use. After the first use, pens can be stored at room temperature for 28 days, away from heat and sunlight.
Important Note
The information above is provided for educational purposes only and should not replace professional medical advice. Please consult a qualified healthcare provider for personalized guidance on medication safety, suitability, and proper use.